Jagiellonian University Repository

Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma : a subgroup analysis of a phase 2 study

pcg.skipToMenu

Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma : a subgroup analysis of a phase 2 study

Bibliographic description

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)